Clinical and hematologic effects of triethylene melamine
- 30 November 1953
- journal article
- review article
- Published by Elsevier in American Journal Of Medicine
- Vol. 15 (5), 684-694
- https://doi.org/10.1016/0002-9343(53)90157-0
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Triethylene melamine in clinical cancer chemotherapyAmerican Journal Of Medicine, 1952
- Triäthylenmelamin (Tem), ein neuer Stoff zur Behandlung von LeukämienKlinische Wochenschrift, 1952
- Clinical observations on the use of triethylenemelamineCancer, 1952
- Triethylene Melamine Therapy in Hodgkin's and other Malignant DiseasesActa Radiologica, 1951
- UREMIA COMPLICATING LEUKEMIA CHEMOTHERAPYJAMA, 1951
- TRIETHYLENE MELAMINE IN THE TREATMENT OF NEOPLASTIC DISEASEA.M.A. Archives of Internal Medicine, 1951
- Trisethyleneimino-s-Triazine in Human Malignant Disease: A Preliminary TrialBritish Journal of Cancer, 1951
- NITROGEN MUSTARD THERAPY IN HODGKIN’S DISEASEBlood, 1949
- Effect of Urethane on Malignant Diseases: Clinical, Hematologic and Histologic Observations on Patients with Carcinoma, Leukemia and Related DiseasesAmerican Journal of Clinical Pathology, 1948
- NITROGEN MUSTARD THERAPYJAMA, 1946